Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • aliceb
    Member
    • Jan 2010
    • 18

    #1

    Should I sequence un-replicated blocks in RNAseq?

    Hi all,

    I am designing a new experiment to sequence transcriptomes from wasps. I have 3 treatment "environments" and 4 replicate populations in each (kept separate throughout), for a total of 12 separate rearing cages.

    I want to compare expression among treatment "environments", but of course the replicate populations should be taken into account. They are separate pools of individuals that have evolved separately. The problem is that my experimental wasps are not very cooperative, and I simply don't have 3 individuals from some of my replicate populations. So, I am trying to decide how to go about sequencing them.

    Can I assume similar variance across populations, and so get a good estimate of expression from non-replicated populations? Is this a terrible idea because they are coming from different genetic backgrounds?

    For some of my replicate populations, I have plenty of individuals. For others, just one. So, I am wondering how useful it will be to sequence those single individuals. As an alternative, I can use my limited resources differently, and just sequence more individuals from fewer replicate populations. This will tell me less about my experiment in general, but more about that population.....

    According to this thread, I can analyze using edgeR if I just have good replication in some groups: http://seqanswers.com/forums/showthread.php?t=46068

    Does anyone have experience with this? In EdgeR or other programs?

    For comparison/context, in previous sequencing from these populations, the wasps were more cooperative and I used the following design to analyze differential expression in DESeq2 (35 libraries in total):


    sel.line <- factor(c(rep("GroupB",11),rep("GroupD",12), rep ("GroupE", 12)))

    block <- factor(c(rep("1", 3), rep("2", 3), rep("3", 3), rep("4", 2),
    rep("1", 3), rep("2", 3), rep("3", 3), rep("4", 3),
    rep("1", 3), rep("2", 3), rep("3", 3), rep("4", 3)))

    ExpDesign3 <- data.frame(
    row.names = colnames(countdata3),
    sel.line = sel.line,
    block = block)

    CDS3 <- DESeqDataSetFromMatrix(countData = countdata3, colData=ExpDesign3, design= ~ block + sel.line)
    "

    In this case, block refers to replicate cages within treatment, and sel.line is the level of "interest" in my study.

    Many thanks,
    Alice

Latest Articles

Collapse

  • SEQadmin2
    Beyond CRISPR/Cas9: Understand, Choose, and Use the Right Genome Editing Tool
    by SEQadmin2



    CRISPR/Cas9 sparked the gene editing revolution for both research and therapeutics.1 But this system still showed severe issues that limited its applications. The most prominent were the heavy reliance on PAM sequences, delivery limitations, double-stranded breaks that prompt unintended edits and cell death, and editing inefficiency (both in targeting and in knock-in reliability).

    Despite this, “CRISPR helped turn genome editing from a specialized technique into
    ...
    07-31-2026, 11:01 AM
  • SEQadmin2
    Proteomic Platforms: How to Choose the Right Analytical Strategy to Improve Detection and Clinical Applications
    by SEQadmin2


    Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.

    The systematic characterization of the human proteome has
    ...
    07-20-2026, 11:48 AM
  • SEQadmin2
    Advanced Sequencing Platforms Tackle Neuroscience’s Toughest Genomics Problems
    by SEQadmin2



    Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
    ...
    07-09-2026, 11:10 AM

ad_right_rmr

Collapse

News

Collapse

Topics Statistics Last Post
Started by SEQadmin2, Yesterday, 10:13 AM
0 responses
14 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 07-31-2026, 02:55 AM
0 responses
29 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 07-24-2026, 12:17 PM
0 responses
22 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 07-23-2026, 11:41 AM
0 responses
21 views
0 reactions
Last Post SEQadmin2  
Working...